These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3026971)

  • 1. HTLV-III infection of EBV-genome-positive B-lymphoid cells with or without detectable T4 antigens.
    Salahuddin SZ; Ablashi DV; Hunter EA; Gonda MA; Sturzenegger S; Markham PD; Gallo RC
    Int J Cancer; 1987 Feb; 39(2):198-202. PubMed ID: 3026971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementation between infecting Epstein-Barr virus and intrinsic viral genomes in human lymphoid cell lines.
    Lidin BI; Lamon EW; Cloud G; Soong SJ
    Intervirology; 1982; 18(1-2):66-75. PubMed ID: 6288617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
    McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
    J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
    Klein G; Ehlin-Henriksson B; Schlossman SF
    J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV.
    Klein G; Sugden B; Leibold W; Menezes J
    Intervirology; 1974; 3(4):232-44. PubMed ID: 4376804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.
    Slovin SF; Frisman DM; Tsoukas CD; Royston I; Baird SM; Wormsley SB; Carson DA; Vaughan JH
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2649-53. PubMed ID: 6283539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.
    Lidin BI; Lamon EW
    Arch Virol; 1983; 77(1):13-25. PubMed ID: 6312934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Epstein-Barr virus in B-lymphoblastoid cells by human immunodeficiency virus type 1.
    Lai PK; Li X; Volsky DJ
    Int J Cancer; 1989 Jun; 43(6):1104-11. PubMed ID: 2543643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH; Wills A; Reece E; Fox Z
    Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.
    Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D
    Intervirology; 1975; 5(6):319-34. PubMed ID: 181343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations.
    Pahwa S; Pahwa R; Saxinger C; Gallo RC; Good RA
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8198-202. PubMed ID: 2999797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Variants of the interaction of the human T-cell leukemia virus (HTLV-I) with the B-cells of lymphoblastoid lines].
    Iakovleva LS; Pavlish OA; Tupitsin NN; Gurtsevich VE
    Vopr Virusol; 1992; 37(5-6):232-5. PubMed ID: 1337802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1].
    Kwon KW
    Hokkaido Igaku Zasshi; 1995 Mar; 70(2):315-28. PubMed ID: 7774883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
    J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Productive Epstein-Barr viral infection of the human lymphoblastoid cell line 6410 with release of early antigen inducing and transforming virus.
    Traul KA; Stephens R; Gerber P; Peterson WD
    Int J Cancer; 1977 Aug; 20(2):247-55. PubMed ID: 197026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.
    De Rossi A; Franchini G; Aldovini A; Del Mistro A; Chieco-Bianchi L; Gallo RC; Wong-Staal F
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4297-301. PubMed ID: 2424024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection of leukaemic B lymphocytes by Epstein Barr virus.
    Doyle MG; Catovsky D; Crawford DH
    Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT; Bluestein HG; Zvaifler NJ
    J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
    Doyle MG; Crawford DH
    Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.